The German vaccine maker plans to…
The German vaccine maker plans to wind down operations at [...]
The U.S. Supreme Court has…
The U.S. Supreme Court has temporarily reinstated online access to [...]
The company chalks up a financial…
The company chalks up a financial impact of about 150 [...]
The early FDA approval doesn’t…
The early FDA approval doesn’t change Pfizer and Arvinas’ plan [...]
Four years after gaining FDA…
Four years after gaining FDA approval for Auvelity to treat [...]
Shortly after laying out $75…
Shortly after laying out $75 million upfront for Corstasis Therapeutics [...]
The company looks to achieve an…
The company looks to achieve an “amicable resolution as soon [...]
A surprise interim trial miss in…
A surprise interim trial miss in ivonescimab’s closely watched Harmoni-3 [...]
As Eli Lilly gets off to the races…
As Eli Lilly gets off to the races with the [...]
Bristol Myers Squibb’s growth…
Bristol Myers Squibb’s growth portfolio is offsetting declines in older [...]